Join to view full profile
10313 Georgia AveSte 309Silver Spring, MD 20902
Phone+1 301-681-7000
Dr. Lockshin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Indiana University School of MedicineResidency, Dermatology, 2003 - 2005
MedStart Georgetown University HospitalResidency, Dermatology, 2002 - 2003
MedStar Health Georgetown University/Georgetown HospitalInternship, Internal Medicine, 2001 - 2002
Georgetown University School of MedicineClass of 2001
Certifications & Licensure
FL State Medical License 2024 - Present
CA State Medical License 2024 - 2028
MD State Medical License 2005 - 2028
TN State Medical License 2024 - 2027
CO State Medical License 2024 - 2027
GA State Medical License 2024 - 2027
MI State Medical License 2024 - 2027
American Board of Dermatology Dermatology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification NexTech with NewCropRx, NexTech Systems, LLC, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification NexTech Practice 2012, NexTech Systems, LLC, 2012, 2014-2017
- Resident Teaching Award Johns Hopkins University, Dept of Dermatology, 2011-2012
Clinical Trials
- Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis Start of enrollment: 2006 Apr 01
- Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
- A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) Start of enrollment: 2012 May 18
Publications & Presentations
PubMed
- Dupilumab treatment improves signs, symptoms, and quality of life in children aged 6 months to 11 years with moderate-to-severe atopic dermatitis: a plain language sum...Elaine C Siegfried, Michael J Cork, Benjamin Lockshin, Norito Katoh, Wendy Smith Begolka
The Journal of Dermatological Treatment. 2026-12-01 - Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus: A Randomized Clinical Trial.Aaron R Mangold, Benjamin Lockshin, Zhihong Lai, Rong Rong, Haq Nawaz
JAMA Dermatology. 2026-09-23 - 14 citationsRoflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.Melinda J Gooderham, Javier Alonso-Llamazares, Jerry Bagel, Neal Bhatia, Michael Bukhalo
JAMA Dermatology. 2025-07-01
Press Mentions
U.S. Dermatology Partners Expands Further in Virginia by Partnering with Robert Silverman, M.D.February 15th, 2018
20th Annual DC Lupus SummitMarch 19th, 2016
Committees
- Member, National Psoriasis Foundation - Board of Directors 2015 - Present
- Chair, National Psoriasis Foundation Research Committee 2015 - Present
- Member, The Skin Cancer Foundation - Board of Directors 2015 - Present
- President, Washington, D.C. Dermatological Society 2013 - 2014
- Vice-President, Washington, D.C. Dermatological Society 2012 - 2013
Professional Memberships
- Fellow
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: